Visit other SMART + STRONG sites:
POZREAL HEALTHTU SALUD
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Life Expectancy With HIV Increases Dramatically
HIV Eradication: One Step Closer
Scientists Crack Integrase Inhibitor Mystery
Gilead Reports Success With Quad Pill and Boosting Drug
New Hope for HIV Eradication
Study: Demand for HIV Vaccine Will Depend on How Good It Is
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

April 17, 2009

BMS Launches Co-Pay Assistance Program

Bristol-Myers Squibb (BMS) announced today that it is launching its own co-payment assistance program for Reyataz (atazanavir) and Sustiva (efavirenz) starting April 30.

BMS is working with Gilead Sciences, its partner in the manufacture and sales of Atripla (efavirenz, tenofovir and emtricitabine), to offer co-payment assistance for that medication soon. Videx EC (didanosine) and Zerit (stavudine) are not included in the co-payment program.

The program is designed for people who have private health insurance and high co-payments for their HIV medication. People will be responsible for paying the first $50 of their total co-payments involving an antiretroviral regimen containing either Reyataz or Sustiva. The BMS program kicks in after the first $50 and covers up to $200 per month for one year. This would reduce the co-payment for a person who currently pays $275 at the pharmacy each month to $75.

Federal law prohibits companies from offering co-payment assistance to people who are eligible for Medicaid, Medicare and AIDS drug assistance programs (ADAPs). The Massachusetts law that created statewide mandatory health insurance also prohibits companies from providing co-payment assistance to anyone in that state.

People should be able to pick up a card for the program at their doctor’s office or pharmacy after April 30. People can also contact the Access Virology program after April 30 at BMS (888.281.8981) to obtain a card by mail. BMS is working to get small specialty pharmacies and mail-order businesses to accept the card, but says it might take a little longer for those types of businesses to join the program. If people have trouble getting their pharmacy or mail-order business to accept the card, people can contact Access Virology to get reimbursements for their co-payments after April 30.

Search: Bristol-Myers Squibb, BMS, Reyataz, atazanavir, Sustiva, efavirenz, Atripla, tenofovir, emtricitabine, Videx EC, didanosine, Zerit, stavudine, co-payment, discount card


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 2 (of 2 total)    

Tim Horn, AIDSmeds.com, New York, NY, 2009-04-22 15:27:01
These programs are for people with PRIVATE health insurance who face out-of-pocket co-payments for their prescriptions. Generally speaking, those who get their meds via public Medicaid, Medicare or ADAPs do not have co-pays and therefore do not qualify for this (or other) program.

David, NYC, 2009-04-22 15:02:58
if "Federal law prohibits companies from offering co-payment assistance to people who are eligible for Medicaid, Medicare and AIDS drug assistance programs (ADAPs)" WHO is eligible???

comments 1 - 2 (of 2 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
My Cool Tools
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine
Conference Coverage

17th Conference on Retroviruses and Opportunistic Infections (CROI 2010)
San Francisco, CA
February 16-19, 2010


5th IAS Conference on HIV Pathogenesis Treatment and Prevention (IAS 2009)
Cape Town, South Africa
July 19-22, 2009


16th Conference on Retroviruses and Opportunistic Infections (CROI 2009)
Montréal, Canada
February 8-11, 2009

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2010 Smart + Strong. All Rights Reserved. Terms of use and Your privacy